21st February 2020 – The Transdermal
Drug Delivery System Market report provides in-depth analysis and
insights into developments impacting businesses and enterprises on global and
regional level. The study covers the global Transdermal Drug Delivery System
Market presentation regarding revenue contribution from multiple segments and
covers a comprehensive analysis of key market trends, drivers, restraints, and
opportunities influencing revenue growth of the industry. This research report
studies the market size, industry status and forecast, competition landscape
and growth opportunities.
Global transdermal drug delivery system
market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward
sedentary lifestyle that encourages chronic disorders. Transdermal drug
delivery is a painless process of delivering drug in the body part. TDDS
delivers drug through the skin in pre-decided and regulated rate. It offers
extended therapeutic effects, lesser side-effects, improved patient compliance,
better bioavailability, and easy cessation of drug treatment. Transdermal drug
delivery is much preferred today as compared to the conventional oral method or
injectables.
Request
a Sample Copy @ https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market/request-sample
Transdermal drug delivery systems market
is witnessing growth due to the factors like increasing consumer preference for
minimally invasive procedures for chronic disorders and multiple advantages
associated with TDDS. Infusion of drug could be effectively monitored and
projected creditably through transdermal drug delivery method, which makes it
convenient to maintain steady level of drug. However, transdermal drug delivery
system industry is restrained by constrained areas of delivery and slow
infusion rate hydrophilic drugs.
Recent years has introduced multiple
drugs that could be delivered through transdermal route. Also, the existing
market players in this market are focusing on mergers and acquisition to create
niche market.Transdermal drug delivery system market is categorized on the
basis of delivery system type, application, and geography. On the basis of
delivery system type, the market is divided into active (matrix system,
reservoir system), passive (electrical based, structure based) and others.
Electrical based systems can be further classified as iontophoresis,
electroporation and sonophoresis. Passive delivery system segment is predicted
to lead the market of transdermal drug delivery system due to rise in chronic
disorders.
Based on application, transdermal drug
delivery systems industry is divided into analgesics, hormone replacement
therapy, motion sickness, cardiovascular disorder, smoking cessation, and
others. Cardiovascular disorder segment is projected to hold larger market
share of transdermal drug delivery system owing to the increase in cases of
heart-related disorders.
Some of the major objectives of this
report:
·
To present detailed analysis of
the market structure along with forecast of the various segments and
sub-segments of global Transdermal Drug Delivery System Market.
·
To provide insights about
factors affecting the market growth. To analyze the Transdermal Drug Delivery
System Market based on various factors- price analysis, supply chain analysis,
porter five force analysis etc.
·
To provide historical and
forecast revenue of the Transdermal Drug Delivery System Market segments and
sub-segments with respect to four main geographies and their countries- North
America, Europe, Asia, and Rest of the World.
·
To provide country level
analysis of the market for segment by application, product type and
sub-segments.
·
Trace and analyze competitive
developments such as joint ventures, strategic alliances, mergers and
acquisitions, new product evolutions, and research and developments in the
Market.
·
To present strategic profiling
of key players in the market, comprehensively analyzing their basic
capabilities.
Some
of the Major Market Players Are:
Acrux Limited, Echo Therapeutics,
Inc., Johnson & Johnson, Bristol-Myers Squibb Company, GlaxoSmithKline plc,
Boehringer Ingelheim GmbH, Mylan N.V., Bayer AG, Endo Pharmaceuticals Inc. and
Novartis AG.
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment